Acquisition of Endospan - Schedule Identifiable Intangible Assets Recognized (Details) - Endospan $ in Thousands |
May 18, 2026
USD ($)
|
|---|---|
| Business Combination [Line Items] | |
| Total identifiable intangible assets | $ 72,400 |
| In-process research and development (“IPR&D”) | |
| Business Combination [Line Items] | |
| In-process research and development (“IPR&D”) | 38,900 |
| Developed technology | |
| Business Combination [Line Items] | |
| Identifiable intangible assets | $ 31,800 |
| Estimated Useful Life (Years) | 10 years |
| Trade name | |
| Business Combination [Line Items] | |
| Identifiable intangible assets | $ 1,700 |
| Estimated Useful Life (Years) | 15 years |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of identifiable intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible asset, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase in finite-lived intangible asset acquired in business combination, asset acquisition, and from joint venture formation. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase in indefinite-lived asset acquired in business combination, asset acquisition, and from joint venture formation. Excludes goodwill. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|